Vanguard sells shares of 7 companies worth Rs 998 cr via block deals
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open market transactions.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
UBS Offloads Shares Worth Rs 480 Crore In Four Companies
UBS Principal Capital Asia Ltd. sold stakes in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd. and Marksans Pharma Ltd. worth Rs 480 crore, according to the bulk deal data on the NSE. Concord had 7.4 lakh shares sold by UBS, representing a 0.7% stake at Rs 2589.86 apiece, aggregating to a total value of 191 crore.
Vanguard Group Buys Rs 998 Cr Shares in 7 Companies
Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord Biotech and Five-Star Business Finance, for a total of Rs 998 crore.
Vanguard Group Acquires Rs 998 Crore in Indian Companies
US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold shares worth Rs 479.
Bulk deals : Vanguard Group buys shares worth Rs 1000 crore in 7 companies
On September 20, The Vanguard Group Inc A/C Vanguard Total International Stock Index Fund, The Vanguard Group Inc A/C Vanguard Emerging Markets Stock Index Fund A Series of Vanguard International, and UBS Principal Capital Asia Limited bought and sold stakes in various companies via bulk deals.
Vanguard Group sells shares of 7 companies worth Rs 998 cr
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open ma
thearabianpost7h
Vanguard Group Invests Rs 998 Crore in Seven Firms
Dubai A significant investment has emerged from the Vanguard Group, a leading US-based financial services company, which has ...
Number of smallcap stocks offering double-digit returns falls even as bulls dominate the week
Despite the overall positive market sentiment, the rally didn't fully extend to small-cap stocks. This is evident in the ...
Mint2y
Concord Biotech, backed by Rakesh Jhunjhunwala’s firm, files for IPO
Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital markets regulator Securities Exchange ...
health.economictimes.indiatimes1y
CONCORD BIOTECH
Seamless reading experience. Save your favourite. Get updates on your preferred social platform Follow us for the latest news, insider access to events and more.
Morningstar3d
Concord Biotech Ltd CONCORDBIO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...